59892-40-9 Usage
Description
4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one is a synthetic compound characterized by its solid state. It is a vic-triazolo[4,5-b]pyridinone derivative with a b-D-Ribofuranosyl group attached to the 4-position, which contributes to its unique chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one is used as a synthetic intermediate for the development of novel pharmaceutical compounds. Its unique structure allows for the creation of new drugs with potential therapeutic applications, making it a valuable asset in the pharmaceutical industry.
Used in Chemical Research:
As a useful synthetic intermediate, 4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one is also employed in chemical research for the synthesis of various complex molecules. Its versatility in chemical reactions enables researchers to explore new avenues in chemical synthesis and develop innovative compounds with diverse applications.
Used in Material Science:
The solid-state nature of 4-(b-D-Ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one makes it a candidate for use in material science, where it can be utilized in the development of new materials with specific properties. Its unique chemical structure may contribute to the creation of materials with enhanced performance characteristics, such as improved stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 59892-40-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,9 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 59892-40:
(7*5)+(6*9)+(5*8)+(4*9)+(3*2)+(2*4)+(1*0)=179
179 % 10 = 9
So 59892-40-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N4O5/c15-3-5-7(17)8(18)10(19-5)14-6(16)2-1-4-9(14)12-13-11-4/h1-2,5,7-8,10,15,17-18H,3H2,(H,11,12,13)/t5-,7+,8?,10-/m1/s1
59892-40-9Relevant articles and documents
Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4, 5-b]pyridin-5-one derivatives
Wang, Peiyuan,Du, Jinfa,Rachakonda, Suguna,Chun, Byoung-Kwon,Tharnish, Phillip M.,Stuyver, Lieven J.,Otto, Michael J.,Schinazi, Raymond F.,Watanabe, Kyoichi A.
, p. 6454 - 6460 (2007/10/03)
Several 6- and 7-monosubstituted N3,5′-cyclo-4-(β-D- ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives as well as the 5-thiono analogue were synthesized, providing structure - anti-hepatitis C virus (HCV) activity relationships for th
Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity
Wang, Peiyuan,Hollecker, Laurent,Pankiewicz, Krzysztof W.,Patterson, Steven E.,Whitaker, Tony,McBrayer, Tamara R.,Tharnish, Phillip M.,Sidwell, Robert W.,Stuyver, Lieven J.,Otto, Michael J.,Schinazi, Raymond F.,Watanabe, Kyoichi A.
, p. 6100 - 6103 (2007/10/03)
A novel anti-hepatitis C virus (HCV) agent, N3,5′-cyclo-4- (β-D-ribofuranosyl)-vic-triazolo(4,5-b]pyridinin-5-one, was identified, and the structure was confirmed by chemical synthesis from 2-hydroxy-5- nitropyridine.
